Patients with suspected lung cancer are being supported using AI-powered digital avatars at Chelsea and Westminster Hospital (CWH), offering personalised guidance and answers to common questions around tests, scans, and appointments, in multiple languages.
The platform, launched during Lung Cancer Awareness Month, has been developed by trust clinicians to help patients understand the diagnostic process, with the aim of supporting them through their journey. It uses AI-powered digital avatars representing members of the lung cancer team in video content, explaining tests and what to expect when arriving at appointments.
Further resources such as written information and an AI-supported Q&A function are also available in the ten “most translated” languages, CWH notes, to reduce language barriers and improve access to information for patients and families. Feedback from patient advocates and those with lived experience has been central to the development of the platform, the trust shares, shaping the ultimate design and content of the resource.
Orhan Orhan, consultant respiratory physician and clinical lead for the project, points to the anxiety that patients can experience between being referred for suspected lung cancer and getting answers. “Patients often tell us they think of questions after appointments or struggle to remember everything they’ve been told because there is so much information to take in. This new resource gives patients access to reliable information whenever they need it, helping them better understand investigations, prepare for appointments and feel more confident as they move through the pathway.”
With the platform now being rolled out across the suspected cancer pathway, the trust highlights the potential for it to be adapted to other cancer pathways and healthcare services in the future.
Earlier this year, CWH outlined how augmented reality technology was being used to help patients and clinicians visualise women’s health conditions such as endometriosis and prepare for surgical excision.
The technology offers a large-scale, close-up view of anatomically precise 3D models, aiding clinicians in explaining diagnoses or disease progression to patients, and improving understanding of complex women’s health conditions like deep infiltrating endometriosis and uterine fibroids.
Clinicians are able to interact with the model from their computer, enlarging specific regions to show disease impact, and illustrating precisely where areas of endometriosis will be excised during surgery.
Following a 2025 pilot funded by the trust’s charity, CW+, and the Friends of Chelsea and Westminster Hospital, the tech has now reportedly become part of standard practice.
Wider trend: Patient-facing tech
Lincolnshire Partnership NHS Foundation Trust has launched a survey seeking views on its upcoming patient engagement portal, with questions around desired functionality across electronic appointment management, accessing information about care and treatment, and sending and receiving secure messages. Service user engagement has helped to inform what it looked for when choosing a system, the trust explains, and will continue to be influential in determining how it develops in the future. Technical work has been carried out over the last few months to allow the app to connect to existing systems, it adds.
Humber and North Yorkshire Cancer Alliance has awarded a share of £135,000 to three projects run by Humber Health Partnership aiming to improve cancer services and outcomes for patients. The funding is awarded as part of the Cancer Research and Innovation Awards, designed to help turn ideas into improvements to services for those living with, or being tested for, cancer. One of the projects, SACT ePROMs, is a software for monitoring patients undergoing systemic anti-cancer therapy. It reportedly allows patients to report their own progress and symptoms, aiming to create capacity for teams to conduct additional patient reviews.
The Christie NHS Foundation Trust has shared updates on its use of ambient voice technology, offering an insight into how it is being used to support the patient experience. The AVT programme has followed a coordinated roll out across priority use cases, according to the trust, focusing on improving clinical efficiency, documentation quality, and patient experience. It also has plans to extend beyond outpatients to areas including MDTs, board rounds, virtual clinics, and emerging automations, with early scoping work being done with suppliers such as Microsoft Dragon, UiPath, and Cisco. Clinical teams are involved in the design of accompanying templates, prompts, and operational workflows.





